Tag: Chemotherapy

Improvement seen compared with chemotherapy alone for first-line treatment of advanced non-small cell lung cancer

Integration of definitive local therapy relevant if technically feasible and clinically safe to all disease sites

Compared with White patients, Black patients have 71 percent higher odds of cardiotoxicity

Triplet therapy should be offered to patients with de novo metastatic noncastrate prostate cancer with high-volume disease

Progression-free, overall survival significantly lower for female patients receiving chemo mostly in morning

Benefits include histopathologic downstaging, fewer incomplete resections, and better two-year disease control

Physical function remains below that of age-matched controls even five years later

Findings seen among HR-positive, HER2-negative, node-negative early breast cancer patients with recurrence score of 11 to 25

Intervention during chemo linked to lower decreases in VO_2peak, health-related QoL, muscle strength immediately postchemotherapy

Men have lower rates of pathologic complete response than women across tumor subtypes